AIDS/HIV Therapy
Nucleoside analogues and mitochondrial toxicity reviewed
Published in AIDS Weekly, June 7th, 2004
"An evaluation of the U.S. Food and Drug Administration's Adverse Event Reporting System identified that patients co-infected with human immunodeficiency virus and chronic hepatitis C virus who were treated with a regimen of ribavirin and didanosine, with or without stavudine, were at increased risk for events associated with mitochondrial toxicity, including fatal hepatic failure, peripheral neuropathy, pancreatitis, and symptomatic hyperlactatemia/lactic acidosis," investigators in the United States report.
"In response, the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-06-07)
More Articles from AIDS Weekly
- HIV/AIDS Research
Aldo-keto reductase family pathway generates HP1 from S-1360 - HIV/AIDS Research
Phlorotannins from brown alga E. cava inhibit HIV-1 RT and protease - HIV/AIDS Virology
HIV-1 viral load and infectivity reduced in presence of cellular prion protein - HIV/HCV Treatment
HCV therapy with IFN/RBV relatively safe in patients coinfected with HIV and HCV - Pharmaceutical and Drug Development
Novel synthesis of protease inhibitors yield potent anti-HIV activity - AIDS
Scientists discover how AIDS opens cell doors - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
